Skip to main content
School of Public Health
block W logo University of Washington

Anirban Basu

faculty photo
Professor, Health Services
Professor, Pharmacy (primary appt.)
Adjunct Professor, Economics


PhD   University of Chicago, 2004   (Health Economics, Public Policy)
MS   University of North Carolina (Chapel Hill), 1999   (Biostatistics)
MS   University of Toledo, 1997   (Pharmaceutical Sciences)
BS   Jadavpur University, 1995   (Pharmaceutical Sciences)

Contact Info

web site:

office:   H-375Q, Health Sciences Building

Magnuson Health Sciences Center
1959 NE Pacific St.
Seattle, WA 98195-7630

campus box:   357630
voice:   206-616-2986
fax:   206-543-3964


Anirban Basu's work sits at the intersection of microeconomics, statistics, and health policy. His research focuses on comparative and cost effectiveness analyses, causal inference methods, program evaluation, and outcomes research.

Currently the Stergachis Family Endowed Professor and Director of the Pharmaceutical Outcomes Research and Policy Program at the University of Washington, Basu also serves as faculty member in the Department of Health Services and as an adjunct in the Department of Economics. Previously, Basu taught on the faculty of the University of Chicago Department of Medicine, where he remains an external affiliate of the Center for Health and the Social Sciences.

In addition to his position as a faculty research fellow at the National Bureau of Economic Research, Basu is as an associate editor for Health Economics, Journal of Health Economics, and Observational Studies, and has served as panelist or speaker at many economics and health studies conferences, nationally and abroad.

Health econometrics; cost-effectiveness; comparative effectiveness and value of information analyses; quality of life; spill-over effects; substantive focus on cancer, mental health and diabetes
  • HSERV 525
    Advanced Health Services Research Methods III - Causal Inference Using Observational Data

Kim DD, Arterburn DE, Sullivan SD, Basu A. Economic Value of Greater Access to Bariatric Procedures for Patients With Severe Obesity and Diabetes. Med Care. 2018 Jul;56(7):583-588. doi: 10.1097/MLR.0000000000000924.  PMID: 29762271

Basu A, Coe NB, Chapman CG. 2SLS versus 2SRI: Appropriate methods for rare outcomes and/or rare exposures. Health Econ. 2018 Jun;27(6):937-955. doi: 10.1002/hec.3647. Epub 2018 Mar 26.  PMID: 29577493

Park S, Basu A. Alternative evaluation metrics for risk adjustment methods. Health Econ. 2018 Jun;27(6):984-1010. doi: 10.1002/hec.3657. Epub 2018 Mar 26.  PMID: 29577489

Basu A, Meltzer D. Decision Criterion and Value of Information Analysis: Optimal Aspirin Dosage for Secondary Prevention of Cardiovascular Events. Med Decis Making. 2018 Mar 1:272989X17746988. doi: 10.1177/0272989X17746988. [Epub ahead of print]  PMID: 29529923

Slejko JF, Basu A, Sullivan SD. Returns to scientific publications for pharmaceutical products in the United States. Health Econ. 2017 Jul 10. doi: 10.1002/hec.3546. [Epub ahead of print]  PMID: 28695605

Chair, dissertation committee for Benjamin Ely
Antibiotics and acute respiratory tract infections: An evaluation of the CDC’s Get Smart about Antibiotics campaign.

Member, dissertation committee for Sarah Beth Barnett
Economic evaluations of state and local policies: Depression and related outcomes in populations of vulnerable adults

Chair, dissertation committee for David Kim
Loss relative to Efficient Diffusion (LED) - A novel metric for economic evaluation of medical technology and its application to the evaluation of bariatric surgery

Chair, thesis committee for Wei-Jhih Wang
What guides research investments in translational sciences? The case for pharmaceuticals in metastatic cancers

Comparative Effectiveness of Dynamic Patterns of Glucose Lowering Therapies
University of Chicago
PI:   Basu           Dates:    6/1/2016 - 5/30/2017

Innovative Methods for Modeling Lognitudinal Medical Costs
Northwestern University
PI:   Basu           Dates:    9/1/2015 - 8/31/2016

Personalized Medicine Economics Research PriMER
National Institute on Aging (NIA)
PI:   Veenstra           Dates:    7/1/2015 - 6/30/2016

Current and Future Costs of Alzheimer's and Dementia Care
National Institutes of Health (NIH)
PI:   Coe           Dates:    7/1/2015 - 6/30/2019

Comparative Effectiveness of Dynamic Patterns of Glucose Lowering Therapies
University of Chicago
PI:   Basu           Dates:    6/1/2015 - 5/31/2016

WWAMI Practice Transformation Network
Centers for Medicare and Medicaid Services (CMS)
PI:   Flum           Dates:    5/1/2015 - 4/30/2019

Innovative Methods for Modeling Lognitudinal Medical Costs
Northwestern University
PI:   Basu           Dates:    9/1/2014 - 8/31/2015

A Policy Relevant US Trauma Care System Pragmatic Trial for PTSD and Comorbidity
National Institutes of Health (NIH)
PI:   Zatzick           Dates:    7/1/2014 - 6/30/2019

Personalized Medicine Economics Research (PriMER)
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
PI:   Veenstra           Dates:    10/1/2013 - 9/30/2018

A randomized trial of a structured method for prioritizing cancer research
Fred Hutchinson Cancer Research Center (FHCRC)
PI:   Carlson           Dates:    6/1/2013 - 11/30/2015

Innovative Methods for Modeling Longitudinal Medical Costs
Northwestern University
PI:   Basu           Dates:    12/28/2011 - 8/31/2016

Graduate Certificate in Comparative Effectiveness Research

Comparative effectiveness research is a growing field that aims to generate evidence to improve health care decisions for patients and providers. It examines the benefits and risks of different medical or healthcare interventions, including drugs and medical technology. The results of these comparison studies are used by medical professionals to make better informed healthcare decisions and thereby improve patient care.